台股 » 個股 » 生華科 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

生華科

(6492)
可現股當沖
  • 股價
    41.70
  • 漲跌
    ▲0.10
  • 漲幅
    +0.24%
  • 成交量
    63
  • 產業
    上櫃 生技醫療類股
  • 147人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
生華科 (6492)籌碼相關-富邦-西壢 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

富邦-西壢 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/05/1000.00641.0041.10-6180-3.32%
2024/05/0900.00641.4241.35-6180-3.32%
2024/05/0800.00142.0041.60-1180-0.55%
2024/05/0700.00641.2341.25-6180-3.32%
2024/04/2900.00141.5041.30-1183-0.55%
2024/04/2600.001440.6440.70-14182-7.65%
2024/04/2500.00640.7040.70-6182-3.29%
2024/04/1900.00840.4540.70-8186-4.29%
2024/04/1600.00941.4941.25-9184-4.88%
2024/04/0900.00144.0043.55-1191-0.52%
2024/04/08144.7000.0044.2011910.52%
2024/04/0200.00143.8043.95-1192-0.52%
2024/03/29144.3500.0044.1011980.50%
2024/03/25244.45244.4044.5002010.00%
2024/03/22043.1500.0043.1501980.00%
2024/03/06044.0000.0043.4003310.00%
2024/01/3000.00146.7546.75-1595-0.17%
2024/01/24148.30148.0047.9509520.00%
2024/01/0300.00150.6050.60-11,312-0.08%
2024/01/0200.00450.9050.60-41,309-0.31%
2023/12/29551.5000.0050.9051,3080.38%
2023/12/1900.00152.5052.70-11,283-0.08%
2023/12/14154.401053.6153.40-91,274-0.71%
2023/12/111055.3500.0054.10101,2660.79%
2023/12/07154.0000.0053.6011,2580.08%
2023/12/06255.0000.0054.6021,2500.16%
2023/12/051357.521156.0255.8021,2370.16%
2023/12/041558.83257.0060.70131,1971.09%
2023/12/01156.2000.0055.3011,1370.09%
2023/11/2800.00554.7055.00-51,119-0.45%
2023/11/27556.5800.0055.2051,1190.45%
2023/11/24454.9000.0054.3041,0970.36%
2023/11/2300.00654.8055.40-61,099-0.55%
2023/11/221155.81554.6054.8061,0960.55%
2023/11/2110.154.48754.8353.903.11,0770.29%
2023/11/20655.7200.0055.1061,0700.56%
2023/11/1600.00853.8454.60-81,053-0.76%
2023/11/1500.00154.6054.00-11,042-0.10%
2023/11/14954.2300.0054.8091,0330.87%
2023/11/13152.60652.5052.60-51,019-0.49%
2023/11/10655.4700.0054.1061,0100.59%
2023/11/09853.6300.0053.4089480.84%
2023/11/08756.77157.2055.4069290.65%
2023/11/07258.25158.1057.8019040.11%
2023/11/06158.001357.5857.40-12861-1.39%
2023/11/0200.001458.5359.10-14744-1.88%
2023/11/01461.1300.0060.4046900.58%
2023/10/3100.001459.7358.80-14506-2.77%
2023/10/302456.80456.8054.50203695.41%
2023/10/27650.23154.4054.4052402.08%
2023/10/2600.00348.7249.50-3183-1.64%
2023/10/2400.001245.6345.20-12152-7.87%
2023/10/231246.70846.7546.4541492.67%
2023/09/04345.1000.0044.7031561.92%
2023/09/01146.301046.6246.30-9153-5.85%
2023/08/311047.81446.9447.6561513.97%
2023/08/2800.00245.7545.75-2129-1.55%
2023/08/21142.7000.0042.9511250.80%
2023/08/1600.001042.5742.30-10132-7.53%
2023/08/0400.001543.2243.25-15125-11.93%
2023/07/24545.3500.0045.1551244.00%
2023/07/2000.001245.6845.60-12130-9.23%
2023/07/19146.50646.5346.00-5128-3.88%
2023/07/1700.00646.0845.80-6130-4.59%
2023/07/13248.3000.0047.8021251.59%
2023/06/3000.00151.2051.10-1130-0.77%
2023/06/0100.00151.7051.90-1144-0.69%
2023/05/0800.00551.5051.00-5173-2.88%
2023/05/05553.3200.0052.4051762.83%
2023/04/24053.8000.0051.6001810.00%
上櫃「肥貓」董監現形 台嘉碩、大宇資、穩懋、生華科為前四肥Anue鉅亨-30天前
生華科治療新冠、流感等泛病毒感染新藥 將啟動二期臨床Anue鉅亨-2023/11/21
生華科泛病毒感染肺炎新藥 向美申請二期臨床Anue鉅亨-2023/10/19
生華科 相關文章
生華科 相關影音